ISSN 0377-9556 (PRINT)
ISSN 2383-9457 (ONLINE)
ISSN 2383-9457 (ONLINE)
Prediction of drug sensitivity depending on lncRNA/microRNA-based prognostic risk models.
| ncRNA signature of risk model | Sensitive to high-risk group | Sensitive to low-risk group | Ref |
|---|---|---|---|
| m6A/m5C/m1A RNA methylation | Lapatinib, Epothilone, and Paclitaxel | Pazopanib, Phenformin, Ruxolitinib | 10 |
| PANoptosis | MEK inhibitors PD-0325901, Gefitinib, Paclitaxel, and Trametinib | All-trans retinoic acid, Rac family small GTPases inhibitor EHT 1864 and Phenformin | 11 |
| Cuproptosis | Bicalutamide, Epothilone.B, Lapatinib, Paclitaxel, Sorafenib | Lenalidomide, Metformin, Nilotinib, Pazopanib, Temsirolimus | 12 |
| Genomic instability | BI.2536, BIBW2992, Bicalutamide, FTI.277, GW843682X, Paclitaxel, PLX4720, Thapsigargin | - | 16 |